Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a class of therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers using its small molecule nucleotide platform. Co. is developing its product candidate, inarigivir soproxil (inarigivir), for the treatment of chronic hepatitis B virus. Co. has designed its antiviral product candidates, including inarigivir, to selectively activate within infected hepatic cells the cellular protein, retinoic acid-inducible gene 1, to inhibit viral replication and to cause the induction of intracellular interferon signaling pathways for antiviral defense. We show 22 historical shares outstanding datapoints in our SBPH shares outstanding history coverage, used to compute SBPH market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SBPH market cap history over the course of time is important for investors
interested in comparing SBPH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SBPH versus a peer is one thing; comparing
SBPH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SBPH can fluctuate over the course of history.
With this page we aim to empower investors researching SBPH by allowing them to research the SBPH market cap history. |
Free SBPH Email Alerts:
Video: The Importance of Market Cap
